Propuesta de un procedimiento para la construcción y validación de un instrumento psicométrico con base en un cuestionario de conocimientos sobre enfermedad cardiovascular en farmacias comunitarias de España.

Introducción: En la práctica clínica se requiere de herramientas para valorar el conocimiento de los pacientes, siendo los cuestionarios uno de los instrumentos más comunes. En general, los cuestionarios o instrumentos que se utilizan son traducidos o, bien, realizados ad hoc, limitando así su fiabilidad y validez. Objetivo: Desarrollar una propuesta global con el procedimiento para diseñar y validar un cuestionario. Métodos: Se realizaron revisiones bibliográficas en Pubmed/Medline y en Google Scholar de artículos con los siguientes términos: validation questionnaire and desing, developing a questionnaire y validación, diseño y cuestionario, que permitan identificar los pasos y la metodología adecuada para el diseño y la validación de un cuestionario. Resultados: Mediante la revisión se identificaron 78 artículos y se accedió al texto completo de 75 artículos. Con la información obtenida se elaboró una propuesta para diseñar y validar cuestionarios de conocimiento por pacientes. Conclusiones: Se presenta una propuesta de diseño y validación de cuestionario para orientar trabajos con este fin, la cual debe ser validada en futuros estudios

Propuesta de un procedimiento para la construcción y validación de un instrumento psicométrico con base en un cuestionario de conocimientos sobre enfermedad cardiovascular en farmacias comunitarias de España.

Introducción: En la práctica clínica se requiere de herramientas para valorar el conocimiento de los pacientes, siendo los cuestionarios uno de los instrumentos más comunes. En general, los cuestionarios o instrumentos que se utilizan son traducidos o, bien, realizados ad hoc, limitando así su fiabilidad y validez. Objetivo: Desarrollar una propuesta global con el procedimiento para diseñar y validar un cuestionario. Métodos: Se realizaron revisiones bibliográficas en Pubmed/Medline y en Google Scholar de artículos con los siguientes términos: validation questionnaire and desing, developing a questionnaire y validación, diseño y cuestionario, que permitan identificar los pasos y la metodología adecuada para el diseño y la validación de un cuestionario. Resultados: Mediante la revisión se identificaron 78 artículos y se accedió al texto completo de 75 artículos. Con la información obtenida se elaboró una propuesta para diseñar y validar cuestionarios de conocimiento por pacientes. Conclusiones: Se presenta una propuesta de diseño y validación de cuestionario para orientar trabajos con este fin, la cual debe ser validada en futuros estudios

Reliability and external validity of a questionnaire to assess the knowledge about risk and cardiovascular disease and in patients attending Spanish community pharmacies

© 2016 Elsevier España, S.L.U. Objectives To determine the test-retest reliability of a questionnaire, with a validation preliminary, to assess knowledge of cardiovascular risk (CVR) and cardiovascular disease in patients attending community pharmacies in Spain. To complement the external validity, establishing the relationship between an educational activity and the increase in knowledge about CVR and cardiovascular disease. Design Sub-analysis of a controlled clinical study, EMDADER-CV, in which a questionnaire about knowledge concerning CVR was applied at 4 different times. Location Spanish Community Pharmacies. Participants There were 323 patients in the control group, from the 640 who completed the study. Main measurements Intraclass correlation coefficient to assess the reliability in 3 comparisons (post-educational activity with week 16, post-educational activity with week 32, and week 16 with week 32); and the non-parametric Friedman test to establish the relationship between an oral and written educational activity with increasing knowledge. Results For the 323 patients in the 3 comparisons, the intraclass correlation coefficient values were 0.624; 0.608 and 0.801, respectively (fair-good to excellent reliability). So, the Friedman test showed a statistically significant relationship between educational activity and increased knowledge (p < .0001). Conclusions According to the intraclass correlation coefficient, the questionnaire aimed at assessing the knowledge on CVR and cardiovascular disease has a reliability between acceptable and excellent, which added to the previous validation, shows that the instrument meets the criteria of validity and reliability. Furthermore, the questionnaire showed the ability to relate an increase in knowledge with an educational intervention, feature that complements its external validity

Towards a Post-Graduate Level Curriculum for Biodiversity Informatics. Perspectives from the Global Biodiversity Information Facility (GBIF) Community

Biodiversity informatics is a new and evolving field, requiring efforts to develop capacity and a curriculum for this field of science. The main objective was to summarise the level of activity and the efforts towards developing biodiversity informatics curricula, for work-based training and/or academic teaching at universities, taking place within the Global Biodiversity Information Facility (GBIF) countries and its associated network. A survey approach was used to identify existing capacities and resources within the network. Most of GBIF Nodes survey respondents (80%) are engaged in onsite training activities, with a focus on work-based professionals, mostly researchers, policy-makers and students. Training topics include data mobilisation, digitisation, management, publishing, analysis and use, to enable the accessibility of analogue and digital biological data that currently reside as scattered datasets. An initial assessment of academic teaching activities highlighted that countries in most regions, to varying degrees, were already engaged in the conceptualisation, development and/or implementation of formal academic programmes in biodiversity informatics, including programmes in Benin, Colombia, Costa Rica, Finland, France, India, Norway, South Africa, Sweden, Taiwan and Togo. Digital e-learning platforms were an important tool to help build capacity in many countries. In terms of the potential in the Nodes network, 60% expressed willingness to be recruited or commissioned for capacity enhancement purposes. Contributions and activities of various country nodes across the network have been highlighted and a working curriculum framework has been defined. © 2021. Parker-Allie F et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are creditedPeer reviewe

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naive HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012

Background: Generic drug policies are often associated with concerns about the quality and effectiveness of these products. Phase IV clinical trials may be a suitable design to assess the effectiveness and safety of generic drugs. The objective of this study was to describe the effectiveness and the safety of the generic abacavir/lamivudine and efavirenz in treatment-naïve HIV-infected patients. Methods: A monocentric, nonrandomized, open-label, phase IV study in treatment naïve HIV-infected patients 18 years or older with indication to receive abacavir/lamivudine and efavirenz were recruited from a program that provides comprehensive outpatient consultation and continuing care. The primary end-point was to achieve viral load <40 copies/mL at 12 months after baseline to assess effectiveness. Secondary end-point of the study were 1) to asses increasing in T-CD4 lymphocytes levels as accompaniment to asses effectiveness, and 2) to assess both gastrointestinal, skin, and central nervous system symptoms, and lipid profile, cardiovascular risk, renal, and hepatic function as safety profile. Data were determined at baseline, 3, 6, and 12 months. Close clinical monitoring and pharmaceutical care were used for data collection. Wilcoxon matched-pairs signed-rank test was used to compare proportions or medians. Results: Sixty patients were invited to participate in the study; 42 were enrolled and 33 completed the follow-up. Of the nine patients excluded from the study, only one was withdrawn due to adverse events. At 12 months, 31 of 42 patients (73.8 % in intention-to-treat analysis) achieved a viral load of HIV1 RNA <40 copies/mL. There was a significant increase (172 cells/mm3) in the median for CD4 T lymphocyte count. The adverse events were mild and met the safety profile for this antiretroviral regimen, mainly of central nervous system symptoms, skin rash, lipid abnormalities, and an increase of 2 % in the median of the percentage of cardiovascular risk. Conclusions: The clinical outcomes of generic version of abacavir/lamivudine and efavirenz in HIV treatment naïve patients showed the expected safety and effectiveness profile of proprietary ARV drugs. Trial registration: Registro Público Cubano de Ensayos Clínicos (RPCEC) ID: RPCEC00000202. Registered 19 November 2015.This research was made possible by contribution from the Corporación de Lucha Contra el SIDA, Cali-Colombia, and Comité para el Desarrollo de la Investigación (CODI), Universidad de Antioquia, Medellín, Colombia. In addition, Humax Pharmaceutical S.A. provided the antiretroviral drugs

Applying agroclimatic seasonal forecasts to improve rainfed maize agronomic management in Colombia

Climate variability affects crop production in multiple and often complex ways. The development and use hybrid crops with greater productivity and tolerance to climate shocks is one of the approaches to climate adaptation and agricultural intensification. Since hybrid crops are more expensive for the producer, risk management is of paramount importance. Here, we pose that there is high potential for the Colombian maize sector to use crop-specific climate services for risk reduction. We used the CERES-Maize crop model connected to seasonal climate forecasts developed via Canonical Correlation Analysis (CCA) across key maize growing areas in Colombia to assess the performance of a maize-specific agroclimatic forecast to inform two key decisions, namely, the choice of sowing dates and genotypes. We find that the agroclimatic models perform well at discriminating yield categories (above, below, and normal) with discrimination capacity of up to 70–80 % for the ‘below normal’ and ‘above + below normal’ categories. Consistent with this, agroclimatic forecasts typically predict the optimal planting date with an error of 3 pentads or less. They also predict the optimal choice of genotype correctly around 50–70 % of the time depending on the site or season of interest. Notably, we identify specific cases in which the agroclimatic forecast is misleading but argue that the overall value of the forecasts outweighs these cases. Future work should focus on expanding the scope of the agroclimatic prediction to include other relevant farming decisions that are influenced by climate, and on the improvement of climate forecast performance

Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial

<p>Abstract</p> <p>Background</p> <p>Highly active antiretroviral therapy produces a significant decrease in HIV-1 replication and allows an increase in the CD4 T-cell count, leading to a decrease in the incidence of opportunistic infections and mortality. However, the cost, side effects and complexity of antiretroviral regimens have underscored the immediate need for additional therapeutic approaches. Statins exert pleiotropic effects through a variety of mechanisms, among which there are several immunoregulatory effects, related and unrelated to their cholesterol-lowering activity that can be useful to control HIV-1 infection.</p> <p>Methods/design</p> <p>Randomized, double-blinded, placebo controlled, single-center, phase-II clinical trial. One hundred and ten chronically HIV-1-infected patients, older than 18 years and naïve for antirretroviral therapy (i.e., without prior or current management with antiretroviral drugs) will be enrolled at the outpatient services from the most important centres for health insurance care in Medellin-Colombia. The interventions will be lovastatin (40 mg/day, orally, for 12 months; 55 patients) or placebo (55 patients). Our primary aim will be to determine the effect of lovastatin on viral replication. The secondary aim will be to determine the effect of lovastatin on CD4+ T-cell count in peripheral blood. As tertiary aims we will explore differences in CD8+ T-cell count, expression of activation markers (CD38 and HLA-DR) on CD4 and CD8 T cells, cholesterol metabolism, LFA-1/ICAM-1 function, Rho GTPases function and clinical evolution between treated and not treated HIV-1-infected individuals.</p> <p>Discussion</p> <p>Preliminary descriptive studies have suggested that statins (lovastatin) may have anti HIV-1 activity and that their administration is safe, with the potential effect of controlling HIV-1 replication in chronically infected individuals who had not received antiretroviral medications. Considering that there is limited clinical data available on this topic, all these findings warrant further evaluation to determine if long-term administration of statins may benefit the virological and immunological evolution in HIV-1-infected individuals before the use of antiretroviral therapy is required.</p> <p>Trial registration</p> <p>Registration number NCT00721305.</p